Dong, Zhiwan
Harvard University · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center
2 papers on CoChatORCID 0009-0003-9853-2338
Most cited papers
- Verified
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
Postow, M. A., Manuel, M., Wong, P., Yuan, J., Dong, Z., Liu, C., Perez, S., Tanneau, I., Noel, M., Courtier, A., et al. (2015) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 232
- Verified
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Subrahmanyam, P. B., Dong, Z., Gusenleitner, D., Giobbie-Hurder, A., Severgnini, M., Zhou, J., Manos, M., Eastman, L. M., Maecker, H. T., & Hodi, F. S. (2018) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 190
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free